IDM postpones Paris IPO

Immuno-Designed Molecules (Paris, France) postponed its planned IPO on Euronext in Paris, citing market conditions. Earlier this month, the cancer company proposed to sell 8.1 million shares at EUR 10.50-EUR 12.20 through UBS; Oddo et Cie; and Fortis Bank. If sold at the midpoint of EUR 11.35, IDM would have raised EUR 91.9 million ($112 million). Trading was expected to begin on June 17. ...